Financial hardship from low-dose nivolumab under out-of-pocket payment in recurrent/metastatic head and neck squamous cell carcinoma: a counterfactual distributional analysis across seven Asian settings (ESMO Asia 2026) - Oct 1, 2026 - Abstract #573P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Metastases • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck
|
|
Tilanka K. Dahanayake; Tae Jin Kim
|